Malignant melanoma of the vulva: An extension of cutaneous melanoma?

K. M. Moxley, Amanda Nickles Nickles Fader, P. G. Rose, A. S. Case, D. G. Mutch, E. Berry, J. C. Schink, C. H. Kim, D. S. Chi, K. N. Moore

Research output: Contribution to journalArticle

Abstract

Objective: To determine the prognostic significance of the 2002 revisions of the American Joint Committee on Cancer (AJCC) Staging System for cutaneous melanoma in melanoma of the vulva and review the current surgical utilized for treatment of this neoplasm. Methods: Demographic, surgical and outcomes data were obtained from the records of vulvar melanoma patients treated from 1990 to 2006 at five academic medical centers. The 2002 modifications of the AJCC staging system for cutaneous melanoma, Breslow thickness and Clark level, were applied to all subjects. Kaplan-Meier Modeling and Linear Regression analysis were utilized for data analysis. Statistics were performed with SAS v 9.1. Results: Seventy-seven patients were identified with a median age of 62 years. 73% had Stage I/II disease. Surgical radicality did not impact recurrence rates or survival. Breslow thickness was associated with recurrence (p = 0.002) but not survival. Only the 2002 modified AJCC staging criteria were predictive of overall survival (p = 0.006) in patients with malignant melanoma of the vulva. Conclusions: In the largest multi-site series of vulvar melanoma, the AJCC-2002 staging system for cutaneous malignant melanoma appears to be applicable to primary vulvar melanoma. Moreover, surgical radicality was associated with significant morbidity but not with improvement in survival. Utilization of standard operative staging and resection principles in cutaneous melanoma should be used for all vulvar melanoma patients. Moreover, these patients should also be considered for enrollment in cutaneous melanoma clinical trials.

Original languageEnglish (US)
Pages (from-to)612-617
Number of pages6
JournalGynecologic Oncology
Volume122
Issue number3
DOIs
StatePublished - Sep 2011

Fingerprint

Vulva
Melanoma
Skin
Neoplasm Staging
Joints
Survival
Recurrence
Reoperation
Linear Models
Survival Rate
Regression Analysis
Demography
Clinical Trials
Morbidity

Keywords

  • AJCC staging
  • Melanoma
  • Vulva

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Moxley, K. M., Nickles Fader, A. N., Rose, P. G., Case, A. S., Mutch, D. G., Berry, E., ... Moore, K. N. (2011). Malignant melanoma of the vulva: An extension of cutaneous melanoma? Gynecologic Oncology, 122(3), 612-617. https://doi.org/10.1016/j.ygyno.2011.04.007

Malignant melanoma of the vulva : An extension of cutaneous melanoma? / Moxley, K. M.; Nickles Fader, Amanda Nickles; Rose, P. G.; Case, A. S.; Mutch, D. G.; Berry, E.; Schink, J. C.; Kim, C. H.; Chi, D. S.; Moore, K. N.

In: Gynecologic Oncology, Vol. 122, No. 3, 09.2011, p. 612-617.

Research output: Contribution to journalArticle

Moxley, KM, Nickles Fader, AN, Rose, PG, Case, AS, Mutch, DG, Berry, E, Schink, JC, Kim, CH, Chi, DS & Moore, KN 2011, 'Malignant melanoma of the vulva: An extension of cutaneous melanoma?', Gynecologic Oncology, vol. 122, no. 3, pp. 612-617. https://doi.org/10.1016/j.ygyno.2011.04.007
Moxley, K. M. ; Nickles Fader, Amanda Nickles ; Rose, P. G. ; Case, A. S. ; Mutch, D. G. ; Berry, E. ; Schink, J. C. ; Kim, C. H. ; Chi, D. S. ; Moore, K. N. / Malignant melanoma of the vulva : An extension of cutaneous melanoma?. In: Gynecologic Oncology. 2011 ; Vol. 122, No. 3. pp. 612-617.
@article{d8d274bf282b4b0ebf7e878f51371dc5,
title = "Malignant melanoma of the vulva: An extension of cutaneous melanoma?",
abstract = "Objective: To determine the prognostic significance of the 2002 revisions of the American Joint Committee on Cancer (AJCC) Staging System for cutaneous melanoma in melanoma of the vulva and review the current surgical utilized for treatment of this neoplasm. Methods: Demographic, surgical and outcomes data were obtained from the records of vulvar melanoma patients treated from 1990 to 2006 at five academic medical centers. The 2002 modifications of the AJCC staging system for cutaneous melanoma, Breslow thickness and Clark level, were applied to all subjects. Kaplan-Meier Modeling and Linear Regression analysis were utilized for data analysis. Statistics were performed with SAS v 9.1. Results: Seventy-seven patients were identified with a median age of 62 years. 73{\%} had Stage I/II disease. Surgical radicality did not impact recurrence rates or survival. Breslow thickness was associated with recurrence (p = 0.002) but not survival. Only the 2002 modified AJCC staging criteria were predictive of overall survival (p = 0.006) in patients with malignant melanoma of the vulva. Conclusions: In the largest multi-site series of vulvar melanoma, the AJCC-2002 staging system for cutaneous malignant melanoma appears to be applicable to primary vulvar melanoma. Moreover, surgical radicality was associated with significant morbidity but not with improvement in survival. Utilization of standard operative staging and resection principles in cutaneous melanoma should be used for all vulvar melanoma patients. Moreover, these patients should also be considered for enrollment in cutaneous melanoma clinical trials.",
keywords = "AJCC staging, Melanoma, Vulva",
author = "Moxley, {K. M.} and {Nickles Fader}, {Amanda Nickles} and Rose, {P. G.} and Case, {A. S.} and Mutch, {D. G.} and E. Berry and Schink, {J. C.} and Kim, {C. H.} and Chi, {D. S.} and Moore, {K. N.}",
year = "2011",
month = "9",
doi = "10.1016/j.ygyno.2011.04.007",
language = "English (US)",
volume = "122",
pages = "612--617",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Malignant melanoma of the vulva

T2 - An extension of cutaneous melanoma?

AU - Moxley, K. M.

AU - Nickles Fader, Amanda Nickles

AU - Rose, P. G.

AU - Case, A. S.

AU - Mutch, D. G.

AU - Berry, E.

AU - Schink, J. C.

AU - Kim, C. H.

AU - Chi, D. S.

AU - Moore, K. N.

PY - 2011/9

Y1 - 2011/9

N2 - Objective: To determine the prognostic significance of the 2002 revisions of the American Joint Committee on Cancer (AJCC) Staging System for cutaneous melanoma in melanoma of the vulva and review the current surgical utilized for treatment of this neoplasm. Methods: Demographic, surgical and outcomes data were obtained from the records of vulvar melanoma patients treated from 1990 to 2006 at five academic medical centers. The 2002 modifications of the AJCC staging system for cutaneous melanoma, Breslow thickness and Clark level, were applied to all subjects. Kaplan-Meier Modeling and Linear Regression analysis were utilized for data analysis. Statistics were performed with SAS v 9.1. Results: Seventy-seven patients were identified with a median age of 62 years. 73% had Stage I/II disease. Surgical radicality did not impact recurrence rates or survival. Breslow thickness was associated with recurrence (p = 0.002) but not survival. Only the 2002 modified AJCC staging criteria were predictive of overall survival (p = 0.006) in patients with malignant melanoma of the vulva. Conclusions: In the largest multi-site series of vulvar melanoma, the AJCC-2002 staging system for cutaneous malignant melanoma appears to be applicable to primary vulvar melanoma. Moreover, surgical radicality was associated with significant morbidity but not with improvement in survival. Utilization of standard operative staging and resection principles in cutaneous melanoma should be used for all vulvar melanoma patients. Moreover, these patients should also be considered for enrollment in cutaneous melanoma clinical trials.

AB - Objective: To determine the prognostic significance of the 2002 revisions of the American Joint Committee on Cancer (AJCC) Staging System for cutaneous melanoma in melanoma of the vulva and review the current surgical utilized for treatment of this neoplasm. Methods: Demographic, surgical and outcomes data were obtained from the records of vulvar melanoma patients treated from 1990 to 2006 at five academic medical centers. The 2002 modifications of the AJCC staging system for cutaneous melanoma, Breslow thickness and Clark level, were applied to all subjects. Kaplan-Meier Modeling and Linear Regression analysis were utilized for data analysis. Statistics were performed with SAS v 9.1. Results: Seventy-seven patients were identified with a median age of 62 years. 73% had Stage I/II disease. Surgical radicality did not impact recurrence rates or survival. Breslow thickness was associated with recurrence (p = 0.002) but not survival. Only the 2002 modified AJCC staging criteria were predictive of overall survival (p = 0.006) in patients with malignant melanoma of the vulva. Conclusions: In the largest multi-site series of vulvar melanoma, the AJCC-2002 staging system for cutaneous malignant melanoma appears to be applicable to primary vulvar melanoma. Moreover, surgical radicality was associated with significant morbidity but not with improvement in survival. Utilization of standard operative staging and resection principles in cutaneous melanoma should be used for all vulvar melanoma patients. Moreover, these patients should also be considered for enrollment in cutaneous melanoma clinical trials.

KW - AJCC staging

KW - Melanoma

KW - Vulva

UR - http://www.scopus.com/inward/record.url?scp=80051545509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051545509&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2011.04.007

DO - 10.1016/j.ygyno.2011.04.007

M3 - Article

C2 - 21570710

AN - SCOPUS:80051545509

VL - 122

SP - 612

EP - 617

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -